Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

CASMED's Fore-Sight cleared to monitor skeletal muscle

This article was originally published in Clinica

Executive Summary

The US FDA has expanded the 510(k) clearance Fore-Sight Absolute Tissue Oximeter, manufactured by CAS Medical Systems (CASMED), to include skeletal muscle monitoring. Specifically, it is now cleared for this use in infants, children and adolescents weighing 5-50kg. The device was previously cleared to continuously and noninvasively measure oxygen saturation of blood in the brains of critically-ill patients. The expansion will improve monitoring for these patients, Branford, Connecticut-based CASMED believes. Low oxygen saturation levels can indicate anaemia, low cardiac output and shock; monitoring allows clinicians to intervene before the situation becomes life-threatening.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT096524

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel